Similar articles

• When and how to treat chronic lymphocytic leukemia.

  Dighiero G, Binet JL. Dighiero G, et al. N Engl J Med. 2000 Dec 14;343(24):1799-801. doi: 10.1056/NEJM200012143432410. N Engl J Med. 2000. PMID: 11114321 No abstract available.
• Fludarabine for chronic lymphocytic leukemia.

  Copur MS, Ledakis P, Muhvic J. Copur MS, et al. N Engl J Med. 2001 Apr 12;344(15):1166; author reply 1167-8. N Engl J Med. 2001. PMID: 11302141 No abstract available.
• Fludarabine for chronic lymphocytic leukemia.

  Marchetti M, Barosi G, Liberato LN. Marchetti M, et al. N Engl J Med. 2001 Apr 12;344(15):1166-7; author reply 1167-8. doi: 10.1056/NEJM200104123441511. N Engl J Med. 2001. PMID: 11302140 No abstract available.
• [Fludarabine in the treatment of chronic lymphocytic leukemia and other lymphoproliferative disorders].

  Pawelski S. Pawelski S. Acta Haematol Pol. 1995;26(3):263-8. Acta Haematol Pol. 1995. PMID: 8525771 Review. Polish.
• Current results and prospective trials of cladribine in chronic lymphocytic leukemia.

  Tallman MS, Hakimian D. Tallman MS, et al. Semin Hematol. 1996 Jan;33(1 Suppl 1):23-7. Semin Hematol. 1996. PMID: 8714613 Review. No abstract available.